posted on 2021-10-10, 03:15authored byDavid A. Jenkins, Humaira Hussein, Reynaldo Martina, Pascale Dequen-O’Byrne, Keith R. Abrams, Sylwia Bujkiewicz
Additional file 5. Annualised relapse rate ratios (95% credible intervals) of each active treatment compared to placebo for values of the down-weighting factor (alpha) between zero (total down-weighting, i.e. RWE not included) and one (RWE considered at ‘face-value’) using the hierarchical power prior model.